. . . . . . . . . . . . "[Recombinant human TRAIL can both injure and activate human endothelial cells in vitro and in vivo; compared with TNF, TRAIL is potent at causing injury but less effective at stimulating inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2015-08-25T14:39:26+02:00"^^ . . . . . . . . . . . "v3.0.0.0" . "v3.0.0" .